The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Exel Industries SA
F:8YK
|
FR |
|
R
|
Riley Exploration Permian Inc
AMEX:REPX
|
US |
|
A
|
Al Shaheer Corporation Ltd
KAR:ASC
|
PK |
|
U
|
United Tractors Tbk PT
OTC:PUTKF
|
ID |
|
J
|
JSP Industrial Pharmacy (Thailand) PCL
SET:JSP
|
TH |
|
B
|
Bloomberry Resorts Corp
XPHS:BLOOM
|
PH |
|
P
|
PT Resources Holdings Bhd
KLSE:PTRB
|
MY |
|
S
|
Shenzhen Investment Ltd
F:SHS
|
HK |
|
D
|
Dimand Societe Anonyme for The Use and Construction of Real Estate Constructions Services and Participations
ATHEX:DIMAND
|
GR |
|
Focus Graphite Inc
F:FKC0
|
CA |
|
K
|
Khonburi Sugar PCL
SET:KBS
|
TH |
|
111 Inc
F:8110
|
CN |
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
Magadanenergo PAO
MOEX:MAGE
|
RU |
|
O
|
Oberstdorfer Bergbahn AG
XMUN:KVO
|
DE |
|
W
|
Wholetech System Hitech Ltd
TPEX:3402
|
TW |
|
A
|
Arnoldo Mondadori Editore SpA
DUS:MDD
|
IT |
|
Circle8 Group Inc
NASDAQ:CIRC
|
US |
|
Materialise NV
XBRU:MTLS
|
BE |
|
P
|
PBS Finanse SA
WSE:PBF
|
PL |
Exel Industries SA (8YK)’s 12-month stock price forecast through October 2027 has a consensus target of €47.53, implying 185% upside. The forecast is based on price targets from 7 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
8YK is 47.53 EUR with a low forecast of 40.05 EUR and a high forecast of 72.87 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is -2%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next -2 years is 15%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is -19%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is -9%.
Over the last 13 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 3 years is -11%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more